Skip to main content
. Author manuscript; available in PMC: 2019 Jan 5.
Published in final edited form as: J Proteome Res. 2017 Nov 22;17(1):63–75. doi: 10.1021/acs.jproteome.7b00329

Figure 3. Comparison of LC-MRM and LC-PRM Quantification of Differences in a Desthiobiotinylated Peptide Ion Signal due to Target Inhibition by Dasatinib and Erlotinib.

Figure 3

Example peaks for a peptide from ILK are shown, which is a stronger target for Dasatinib compared to Erlotinib. Quantifiable peaks are present in LC-MRM data (A), but not LC-PRM (B). N.D. indicates not detected.